Cantourage Group (HIGH) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
23 Jun, 2026Executive summary
Annual financial statements for the year ended December 31, 2024, were audited and received an unqualified opinion from the independent auditor, confirming compliance with German accounting standards and a true and fair view of the company’s financial position and performance.
The company generated all revenues from service contracts with its wholly owned subsidiaries, Cantourage GmbH and APSAT GmbH.
The board proposes to carry forward the entire net profit for the year.
Financial highlights
Revenue increased to €2,195,385.79, up from €1,662,431.59 year-over-year.
Net income for 2024 was €79,292.20, compared to €38,677.77 in the previous year.
Personnel expenses rose to €1,308,466.85 from €995,363.22 year-over-year.
Other operating expenses increased to €894,968.40 from €609,635.36 year-over-year.
Interest expenses of €13,555.53 were incurred due to a shareholder loan, which was fully repaid within the year.
Outlook and guidance
The company’s ability to continue as a going concern was affirmed by the auditor, with no material uncertainties identified.
The board recommends retaining earnings to strengthen the equity base.
Latest events from Cantourage Group
- EBITDA up 45% in Q2 2026 as high-margin focus boosts profitability and international growth.HIGH
Q2 2026 - Net profit surged to €210,989.14 in H1 2024, driven by higher revenue and one-time income.HIGH
H1 2024 - Q1 2025 revenue soared to EUR 25.6 million, quadrupling year-over-year on robust European demand.HIGH
Q1 2025 TU - Profitable, asset-light cannabis platform drives growth with innovation and telemedicine.HIGH
Investor presentation - Revenue and profit fell, but equity and liquidity remain robust amid higher compliance costs.HIGH
H1 2025 - Q2 2025 revenue more than doubled year-over-year, exceeding last year's total annual sales.HIGH
Q2 2025 TU - Revenue up 148% year-over-year to EUR 75 million, with strong growth and European expansion plans.HIGH
Q3 2025 TU - Revenue up 78% to €3.9M, net income €126K, audit unqualified, all sales intra-group.HIGH
H2 2025 - Q1 2026 saw higher profitability, strong UK growth, and a robust financial position.HIGH
Q1 2026 TU